The Parental Drug Association (PDA) has aimed to educate and expand knowledge of the pharmaceutical industry. They have once again made a great partnership that will grow its reach in the pharmaceutical and biopharmaceutical fields. In February 2021, the PDA partnered with Deloitte Consulting and the Food and Drug Administration (FDA) to help pharmaceutical companies, both established and upcoming, understand compound drugs. The Parental Drug Association has prided itself on providing pharmaceutical and other drug-related workshops at large conventions worldwide. These conferences allow companies to attend, present, and learn from some of the top minds in medicine.
The aim is to provide further courses within the PDA’s conferences that would give new and growing information on environmental drug monitoring, aseptic monitoring of drug product sterility, and improvement on Corrective and Preventative Actions (CAPA). The conferences would also discuss how to improve and initiate new drug safety protocols. Lenox Laser has attended PDA conferences and workshops in previous years.
Past conferences include the October 2019 conference in Gothenburg, where members of our team gave lectures and demonstrations about our products and personal involvement in the industry of pharmaceuticals. In 2020, Lenox Laser attended a PDA conference in Basel, Switzerland, and shared our knowledge on the stage.
Lenox Laser provides pharmaceutical testing services such as Container Closure Integrity Testing (CCIT), CCIT positive testing controls, and CCIT related calibrated leaks. If you require similar services, request a quote today.
Lenox Laser is honored to work alongside the Parental Drug Association. We thank them for their contributions and efforts in the pharmaceutical industry. We look forward to attending future conferences and workshops. If you would like to read more about the new partnership between PDA, Deloitte, and the FDA, click here.